litlas
Log inCreate account

Manuel Hidalgo

Active 1995–2025

173
Papers
49,384
Citations
106
h-index
170
i10-index

Citations

Citations per year for Manuel Hidalgo1976: 1 citations1985: 1 citations1996: 2 citations1998: 1 citations1999: 5 citations2000: 15 citations2001: 34 citations2002: 79 citations2003: 122 citations2004: 187 citations2005: 254 citations2006: 248 citations2007: 251 citations2008: 276 citations2009: 396 citations2010: 452 citations2011: 501 citations2012: 514 citations2013: 576 citations2014: 580 citations2015: 622 citations2016: 627 citations2017: 680 citations2018: 614 citations2019: 1,780 citations2020: 1,978 citations2021: 1,873 citations2022: 1,339 citations2023: 1,010 citations2024: 1,423 citations2025: 657 citations2026: 21 citations1977–1984: no citations, so these years are not shown1986–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,148 citing papers, 28.8% of this breakdownChina: 2,675 citing papers, 12.5% of this breakdownUnited Kingdom: 1,195 citing papers, 5.6% of this breakdownGermany: 1,153 citing papers, 5.4% of this breakdownItaly: 1,117 citing papers, 5.2% of this breakdownJapan: 832 citing papers, 3.9% of this breakdownSpain: 818 citing papers, 3.8% of this breakdownFrance: 791 citing papers, 3.7% of this breakdownCanada: 617 citing papers, 2.9% of this breakdownNetherlands: 578 citing papers, 2.7% of this breakdownAustralia: 441 citing papers, 2.1% of this breakdownSwitzerland: 436 citing papers, 2% of this breakdown
0%28.8%Other 21.4%

Institutions

Fields

  • Medicine56.7%
  • Biochemistry, Genetics and Molecular Biology33.1%
  • Immunology and Microbiology3.4%
  • Engineering1.7%
  • Materials Science1.5%
  • Computer Science0.7%
  • Other2.9%

Topics

  • Pancreatic and Hepatic Oncology Research8.9%
  • Cancer Genomics and Diagnostics4.3%
  • Cancer Cells and Metastasis4.2%
  • Epigenetics and DNA Methylation2.3%
  • Lung Cancer Treatments and Mutations2.2%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Other75.9%

Coauthors

All papers

Open in search
  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Authors: Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee, Mansoor N. Saleh, Marion Harris, Michele Reni, Scot Dowden, Daniel A. Laheru, Nathan Bahary, Ramesh K. Ramanathan, Josep Tabernero, Manuel Hidalgo, David Goldstein, Eric Van Cutsem, Xinyu Wei, José Iglesias, Markus F. Renschler - New England Journal of Medicine 2013 cited by 6,661

  2. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Authors: Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M. Wolpin, Salomon M. Stemmer, Talia Golan, Ravit Geva, Mitesh J. Borad, Katrina S. Pedersen, Joon Oh Park, Robert A. Ramirez, David Gutiérrez Abad, Jaime Feliú, Andrés Muñoz, Mariano Ponz‐Sarvisé, Amnon Peled, Tzipora M Lustig, Osnat Bohana‐Kashtan, Stephen M. Shaw, Ella Sorani, Marya Chaney, Shaul Kadosh, Abi Vainstein Haras, Daniel D. Von Hoff, Manuel Hidalgo - Nature Medicine 2020 cited by 533

  3. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

    Authors: Manuel Hidalgo, Frédéric Amant, Andrew V. Biankin, Eva Budínská, Annette T. Byrne, Carlos Caldas, Robert B. Clarke, Steven de Jong, Jos Jonkers, Gunhild M. Mælandsmo, Sergio Roman‐Roman, Joan Seoane, Livio Trusolino, Alberto Villanueva - Cancer Discovery 2014 cited by 1,760

  4. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    Authors: Siân Jones, Xiaosong Zhang, D. Williams Parsons, Jimmy Lin, Rebecca Leary, Philipp Angenendt, Parminder K. Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno, Seung‐Mo Hong, Baojin Fu, Ming‐Tseh Lin, Eric S. Calhoun, Mihoko Kamiyama, Kimberly Walter, Tatiana Nikolskaya, Yuri Nikolsky, James Hartigan, Douglas R. Smith, Manuel Hidalgo, Steven D. Leach, Alison P. Klein, Elizabeth M. Jaffee, Michael Goggins, Anirban Maitra, Christine A. Iacobuzio–Donahue, James R. Eshleman, Scott E. Kern, Ralph H. Hruban, Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler - Science 2008 cited by 4,055

  5. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    Authors: David M. Hyman, Igor Puzanov, Vivek Subbiah, Jason E. Faris, Ian Chau, Jean‐Yves Blay, Jürgen Wolf, Noopur Raje, Eli L. Diamond, Antoine Hollebecque, Radj Gervais, Maria Elena Elez-Fernandez, Antoîne Italiano, Ralf‐Dieter Hofheinz, Manuel Hidalgo, Emily Chan, Martin Schüler, Susan Frances Lasserre, Martina Makrutzki, Florin Sirzén, Maria Luisa Veronese, Josep Tabernero, José Baselga - New England Journal of Medicine 2015 cited by 1,734

  6. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

    Authors: Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa Manz, Benika J. Pinch, Dipikaa Akshinthala, Ana Verma, Giorgio Gaglia, Yutaka Nezu, Shizhong Ke, Chenxi Qiu, Kenoki Ohuchida, Yoshinao Oda, Tae Ho Lee, Babara Wegiel, John G. Clohessy, Nir London, Sandro Santagata, Gerburg M. Wulf, Manuel Hidalgo, Senthil K. Muthuswamy, Masafumi Nakamura, Nathanael S. Gray, Xiao Zhen Zhou, Kun Ping Lu - Cell 2021 cited by 247

  7. Pancreatic Cancer

    Authors: Manuel Hidalgo - New England Journal of Medicine 2010 cited by 2,569

  8. Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Authors: Annette T. Byrne, Denis Alférez, Frédéric Amant, Daniela Annibali, Joaquı́n Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budínská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles‐Marie, S. Gail Eckhardt, Eva González‐Suárez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunhild M. Mælandsmo, Elisabetta Marangoni, Jean‐Christophe Marine, Enzo Médico, Jens Henrik Norum, Héctor G. Pálmer, Daniel S. Peeper, Pier Giuseppe Pelicci, Alejandro Piris‐Giménez, Sergio Roman‐Roman, Oscar M. Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino - Nature reviews. Cancer 2017 cited by 665

  9. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

    Authors: Chris Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido‐Laguna - Nature Reviews Clinical Oncology 2019 cited by 405

  10. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

    Authors: Joseph E. Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S. Gonzalez, Leo L. Tsai, Jonah Cohen, Bruno Bockorny, Andrea J. Bullock, Benjamin Schlechter, Mary Linton B. Peters, Catherine Conahan, Supraja Narasimhan, Christine Lim, Roger B. Davis, Robert Besaw, Mandeep S. Sawhney, Douglas Pleskow, Tyler M. Berzin, Martin Smith, Tara S. Kent, Mark Callery, Senthil K. Muthuswamy, Manuel Hidalgo - Clinical Cancer Research 2021 cited by 112

  11. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects

    Authors: Miriam Bazán‐Peregrino, Rocio García‐Carbonero, Berta Laquente, Rafael Álvarez, Ana Mato-Berciano, Marta Giménez-Alejandre, Sara Morgado, Alba Rodríguez-García, María Victoria Maliandi, M Carmen Riesco, Rafael Moreno, Mireia M Ginestà, M Pérez-Carreras, Joan B. Gornals, Susana Prados, Sofía Perea, Gabriel Capellá, Ramón Alemany, Ramón Salazar, E. Blasi, C. Blasco, Manel Cascalló, Manuel Hidalgo - Journal for ImmunoTherapy of Cancer 2021 cited by 92

  12. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations

    Authors: Mandeep Sawhney, Audrey H. Calderwood, Nirav Thosani, Timothy R. Rebbeck, Sachin Wani, Marcia Irene Canto, Douglas S. Fishman, Talia Golan, Manuel Hidalgo, Richard S. Kwon, Douglas L. Riegert‐Johnson, Dushyant V. Sahani, Elena M. Stoffel, Charles M. Vollmer, Bashar Qumseya - Gastrointestinal Endoscopy 2022 cited by 134

  13. OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

    Authors: Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A. Eisler, Roland E. Kontermann, Klaus Pfizenmaier, So Young Lee, María dM Vivanco, Pedro P. López‐Casas, Sofía Perea, Muhammad Nadeem Abbas, W. Richter, Laureano Simón, Manuel Hidalgo - Clinical Cancer Research 2020 cited by 102

  14. Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

    Authors: Lucia Nogová, Lecia V. Sequist, José Manuel Pérez García, Fabrice André, Jean‐Pierre Delord, Manuel Hidalgo, Jan H.M. Schellens, Philippe A. Cassier, D. Ross Camidge, Martin Schüler, Ulka N. Vaishampayan, Howard A. Burris, Guangming Tian, Mario Campone, Zev A. Wainberg, Wan‐Teck Lim, Patricia LoRusso, Geoffrey I. Shapiro, Katie Parker, Xueying Chen, Somesh Choudhury, François Ringeisen, Diana Graus-Porta, Dale Porter, Randi Isaacs, Reinhard Buettner, Jürgen Wolf - Journal of Clinical Oncology 2017 cited by 435

  15. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

    Authors: Michele Cioffi, Sara Maria David Trabulo, Manuel Hidalgo, Eithne Costello, William Greenhalf, Mert Erkan, Jörg Kleeff, Bruno Sáinz, Christopher Heeschen - Clinical Cancer Research 2015 cited by 240

  16. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer

    Authors: Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa, Howard A. Liebman, Anita Aggarwal, Mäneka Puligandla, Thomas Caughey, Kenneth A. Bauer, Nancy B. Kuemmerle, Ellice Wong, Ted Wun, Marilyn McLaughlin, Manuel Hidalgo, Donna Neuberg, Bruce Furie, Robert Flaumenhaft, on behalf of CATIQ Investigators - JCI Insight 2019 cited by 170

  17. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

    Authors: Manuel Hidalgo, Stefano Cascinu, Jörg Kleeff, Roberto Labianca, Matthias Löhr, John P. Neoptolemos, Francisco X. Real, Jean‐Luc Van Laethem, Volker Heinemann - Pancreatology 2014 cited by 507

  18. Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

    Authors: Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliú, Mariano Ponz‐Sarvisé, David Gutiérrez Abad, Paul E. Oberstein, Angela Alistar, Andrés Muñoz, Ravit Geva, Carmen Guillén‐Ponce, Mercedes Salgado Fernández, Amnon Peled, Marya Chaney, Irit Gliko-Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein‐Haras, Manuel Hidalgo - Clinical Cancer Research 2021 cited by 88

  19. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

    Authors: Eugene Izumchenko, K. Paz, Daniel Ciznadija, Ido Sloma, Amanda Katz, David Vasquez-Dunddel, Ido Ben-Zvi, Justin Stebbing, William P. McGuire, William Proctor Harris, Robert G. Maki, Andrew Gaya, A Bedi, Stergios Zacharoulis, Rajani Ravi, Leonard H. Wexler, Mohammad Obaidul Hoque, Carlos Rodríguez‐Galindo, Harvey I. Pass, Nir Peled, Angela M. Davies, Ronnie Morris, Manuel Hidalgo, D. Sidransky - Annals of Oncology 2017 cited by 337

  20. PDX-derived organoids model in vivo drug response and secrete biomarkers

    Authors: Ling Huang, Bruno Bockorny, Indranil Paul, Dipikaa Akshinthala, Pierre‐Olivier Frappart, Omar Gandarilla, Arindam Bose, Veronica Sanchez‐Gonzalez, Emily E. Rouse, Sylvain Lehoux, Nicole Pandell, Christine Lim, John G. Clohessy, Joseph E. Grossman, Raul S. González, Sofia Perea Del Pino, George Daaboul, Mandeep Sawhney, Steven D. Freedman, Alexander Kleger, Richard D. Cummings, Andrew Emili, Lakshmi Muthuswamy, Manuel Hidalgo, Senthil K. Muthuswamy - JCI Insight 2020 cited by 130

  21. Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids

    Authors: Qingda Meng, Shanshan Xie, G. Kenneth Gray, M Dezfulian, Omar Gandarilla, Weilin Li, Ling Huang, Dipikaa Akshinthala, Elizabeth Ferrer, Catherine Conahan, Sofia Perea Del Pino, Joseph E. Grossman, Stephen J. Elledge, Manuel Hidalgo, Senthil K. Muthuswamy - Journal for ImmunoTherapy of Cancer 2021 cited by 85

  22. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

    Authors: Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, J. L. Mesías Iglesias, Hui Zhang, Patrick Soon‐Shiong, Tao Shi, N.V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo - Journal of Clinical Oncology 2011 cited by 1,045

  23. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    Authors: Rafael Álvarez, Mónica Musteanu, Elena García-García, Pedro P. López‐Casas, Diego Megı́as, Carmen Guerra, Manuel Muñoz, Yolanda Quijano, Antonio Cubillo, Jesús Rodríguez-Pascual, Carlos Plaza, E. Vicente, S. Prados, Susana Tabernero, Mariano Barbacid, Fernando López‐Ríos, Manuel Hidalgo - British Journal of Cancer 2013 cited by 291

  24. DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

    Authors: Christine A. Iacobuzio–Donahue, Baojin Fu, Shinichi Yachida, Mingde Luo, Hisashi Abe, Clark M. Henderson, F Vilardell, Zheng Wang, Jesse W. Keller, Priya R. Banerjee, Joseph M. Herman, John L. Cameron, Charles J. Yeo, Marc K. Halushka, James R. Eshleman, Marian Raben, Alison P. Klein, Ralph H. Hruban, Manuel Hidalgo, Daniel A. Laheru - Journal of Clinical Oncology 2009 cited by 1,078